Gerresheimer, DE000A0LD6E6

Gerresheimer stock at EUR 28.39 as volume trails average 34.7%

Published on 10/08/2026 at 18:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Gerresheimer stock fell 1.70 percent versus EUR 28.88. The quote was EUR 28.39 on October 8, 2026, with 100,963 shares traded.

Key points in brief

  • Gerresheimer stock was trading at EUR 28.39 at Lang & Schwarz on October 8, 2026, down 1.70 percent from EUR 28.88.
  • Trading volume reached 100,963 shares versus an average of 154,723 shares, a 34.70 percent gap.
  • The stock remained inside its EUR 14.83 to EUR 33.88 52-week range, with market capitalization at EUR 981.6 million.
  • Jefferies kept a Hold rating and a EUR 26.80 price target on September 30, 2026.
Automatisierte Glasampullen-Produktionslinie in steriler Pharmafabrik
Gerresheimer AG mit ISIN DE000A0LD6E6 produziert Glasampullen in hochautomatisierter, steriler Pharmaverpackungsfertigung mit modernster Anlagentechnik, Illustration mit AI erstellt.

Gerresheimer stock (ISIN DE000A0LD6E6) was trading at EUR 28.39 at Lang & Schwarz on October 8, 2026 at 5:53 p.m. CEST, down 1.70 percent from the EUR 28.88 prior close. Volume reached 100,963 shares against an average of 154,723, leaving turnover 34.70 percent below its normal level.

Trading activity stays subdued

The bid stood at EUR 28.30 and the ask at EUR 28.48 at the same after-hours snapshot. The spread between those quotes was EUR 0.18, while the latest price remained inside the day's quoted market.

Range leaves room on both sides

Gerresheimer's 52-week range ran from EUR 14.83 to EUR 33.88 as of October 8, 2026. The EUR 28.39 price was EUR 5.49 below the yearly high, equal to 16.21 percent below that level, and EUR 13.56 above the low.

Market capitalization stood at EUR 981.6 million on October 8, 2026, while the quoted trailing P/E ratio was minus 2.45. The negative ratio reflects the earnings basis used by the market-data quote and should be read alongside the company's latest operating update rather than in isolation.

On September 30, 2026, EQS News reported Gerresheimer's preliminary second-quarter results and said the half-year report was expected at the end of November 2026.

Analyst target remains below price

On September 30, 2026, FinanzNachrichten reported that Jefferies kept Gerresheimer at Hold with a EUR 26.80 price target. The target sits EUR 1.59 below the Lang & Schwarz price, placing the analyst reference below the latest German-market indication.

Comparison with peers

Gerresheimer: minus 1.70 percent, P/E -2.45, market capitalization EUR 981.6 million
DAX (Xetra, EUR): , ,
MDAX (Xetra, EUR): , ,

Price remains below the prior close

Gerresheimer's after-hours price of EUR 28.39 at Lang & Schwarz on October 8, 2026 at 5:53 p.m. CEST stood below the EUR 28.88 prior close from October 7, 2026. The further course of trading is shown by the continuously updated real-time quote of Gerresheimer stock.

Gerresheimer stock facts

  • Company: Gerresheimer AG
  • ISIN: DE000A0LD6E6
  • WKN: A0LD6E
  • Ticker: GXI
  • Primary exchange: Xetra
  • Price Lang & Schwarz as of October 8, 2026, 5:53 p.m. CEST: EUR 28.39
  • Change versus prior close: minus 1.70 percent
  • Prior close Lang & Schwarz October 7, 2026: EUR 28.88
  • Market capitalization: EUR 981.6 million as of October 8, 2026
  • 52-week range: EUR 14.83-EUR 33.88 as of October 8, 2026
  • Sector / Industry: Healthcare / Medical Instruments and Supplies

Market context: Market report DAX.

More news and analyses on Gerresheimer stock

Disclaimer...

en | DE000A0LD6E6 | GERRESHEIMER | boerse | 70268390 | bgmi